Edward Stelmakh - 15 Feb 2024 Form 4/A - Amendment Insider Report for OptimizeRx Corp (OPRX)

Role: CFO/COO
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol: OPRX
Transactions as of: 15 Feb 2024
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 27 Dec 2024, 16:38:57 UTC
Date Of Original Report: 24 Apr 2024
Previous filing: 22 Apr 2024
Next filing: 07 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPRX	Common Stock	Award	$0	0	0%	$0.000000	33,365	15 Feb 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 24, 2024, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently understated in column 5 the number of shares directly owned by the reporting person following the reported transaction. This inadvertent understatement has been corrected in this amended filing. This understatement also affected the holdings reported in subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing.

Content

On April 24, 2024, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently understated in column 5 the number of shares directly owned by the reporting person following the reported transaction. This inadvertent understatement has been corrected in this amended filing. This understatement also affected the holdings reported in subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing.